Boston Scientific told the US Securities and Exchange Commission (SEC) on 8 September that a 25 August network outage will likely hit its third-quarter and full-year results1. It filed under Item 1.05 of the 8-K form, the item for a material cybersecurity incident. The outage disrupted manufacturing and the processing and shipping of orders worldwide, and the company said it is unlikely to meet the net sales growth and adjusted earnings-per-share guidance it gave on 29 July.
At filing, the medical-device maker said its major distribution centres were shipping at or above normal levels and manufacturing had resumed at most sites. It named no attacker and no ransom demand2. It promised more detail on its 28 October results call.
Boston Scientific first reported the outage on 26 August and moved it to Item 1.05 a fortnight later. The SEC's four-business-day clock starts when a company decides an incident is material, not when it detects one, which is how a filing 14 days after the outage can still be on time. Stryker, another medical-device maker, declared its March device wipe material in April but kept its full-year guidance; Boston Scientific has gone further and warned on the guidance itself.
